Evidence map›Paper›PMID 41165334›Full record

ArticlemSphere2025

Host-specific bacterial modulation of airway gene expression and alternative splicing.

Mian Horvath, Hyeon Gu Kang, Te-Chia Wu, Elizabeth Aiken, Diana Cadena Castaneda, Sema Akkurt, Florentina Marches, Olga Anczuków, Karolina Palucka, Julia Oh

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Mian HorvathThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Hyeon Gu KangThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Te-Chia WuThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Elizabeth AikenThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Diana Cadena CastanedaThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Sema AkkurtThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Florentina MarchesThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Olga AnczukówThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Karolina PaluckaThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Julia OhThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.ORCID 0000-0002-5534-7023

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Paul Robson · 1985 to 2026
$61.9M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Damien Chaussabel · 2019 to 2026
$23.1M
Developing a bioprinted ventilated lung alveolar platform for investigating microbial interactions and influenza responseR01AI186386 · NIAID · DUKE UNIVERSITY · PI OH, JULIA, OZBOLAT, IBRAHIM · 2025 to 2025
$3.2M
Metagenomes to Therapeutics: Defining the Rules for Engineering the Skin MicrobiomeDP2GM126893 · NIGMS · JACKSON LABORATORY · PI OH, JULIA · 2017 to 2017
$2.8M
Molecular Mechanisms of Staphylococcus Epidermidis Strain DiversityR01AR078634 · NIAMS · JACKSON LABORATORY · PI OH, JULIA · 2021 to 2025
$2.5M
The UConn/JAX-GM Training Program in Genomic ScienceT32HG010463 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Mark D ADAMS, Christine R Beck · 2020 to 2026
$1.5M
Skin Microbiome of Monogenic Skin DisordersR21AR075174 · NIAMS · JACKSON LABORATORY · PI OH, JULIA · 2019 to 2022
$466k
NCI NIH HHS P30 CA034196NHGRI NIH HHS T32 HG010463NIAID NIH HHS R01 AI186386NIAID NIH HHS U19 AI142733NIAMS NIH HHS R01 AR078634NIAMS NIH HHS R21 AR075174NIGMS NIH HHS DP2 GM126893NIH HHS T32HG010463NIH HHS U19AI142733
6 · The paper itself

Abstract

The human microbiome varies extensively between individuals. While there are numerous studies investigating the effects of inter-individual differences on microbiome composition, there are few studies investigating inter-individual effects on microbial modulation of the host or host-specific effects. To address this knowledge gap, we colonized human bronchial epithelial air-liquid interface tissue cultures generated from six different adults with one of three phylogenetically diverse bacteria and compared how each microbe differentially modulated host gene expression in each of the six donors. Microbial treatment had the strongest effect on transcription, followed by donor-specific effects. Gene pathways differed markedly in their donor and microbe specificity; interferon expression was highly donor-dependent, while transcription of epithelial barrier and antibacterial innate immunity genes was predominantly microbially driven. Moreover, we evaluated whether microbial regulation of alternative splicing was modulated by the donor. Strikingly, we found significant nonredundant, donor-specific regulation of alternative splicing exclusively in the gram-positive commensal microbes. These findings highlight that microbial effects on the human airway epithelium are not only species-specific but also deeply individualized, underscoring the importance of the host context in shaping microbe-induced transcriptional and splicing responses.IMPORTANCEMicrobiota are integral regulators of host gene expression, utilizing diverse mechanisms that are shaped by the interplay between microbiome composition and inter-individual differences, i.e., host-specific factors. While previous studies have characterized inter-individual variation in microbiome composition and the effects of variable microbiome composition on the host, the extent to which host-specificity itself regulates host-microbe interactions remains poorly understood. In this study, we address this gap by characterizing changes in epithelial gene expression from six different human donors following colonization with one of three phylogenetically diverse bacteria. By systematically comparing donor-specific responses, we demonstrate that host specificity is a key determinant of the host transcriptional response to microbial colonization. Importantly, we demonstrate that the effects of host specificity are not uniform, but instead are dependent on the colonizing microbe. Our findings underscore the complexity of host-microbe relationships and establish host specificity as a significant factor shaping host-microbe interactions.

Indexed as

Alternative SplicingBacteriaBronchiGene ExpressionHost Microbial InteractionsHost SpecificityMicrobiotaRespiratory MucosaAdultHumansdonor host specific responseepitheliumhost-microbiome interactionsrespiratory microbiomesplicing

Identifiers

PMID41165334
PMCPMC12646005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.